Quinethazone
![]() | |
Systematic (IUPAC) name | |
---|---|
7-chloro-2-ethyl-4-oxo-1,2,3,4-tetrahydroquinazoline- 6-sulfonamide | |
Clinical data | |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration | Oral |
Legal status |
|
Identifiers | |
CAS Number |
73-49-4 ![]() |
ATC code | C03BA02 (WHO) |
PubChem | CID 6307 |
IUPHAR/BPS | 7289 |
DrugBank |
DB01325 ![]() |
ChemSpider |
6068 ![]() |
UNII |
455E0S048W ![]() |
KEGG |
D00461 ![]() |
ChEMBL |
CHEMBL1532 ![]() |
Chemical data | |
Formula | C10H12ClN3O3S |
Molar mass | 289.739 g/mol |
| |
| |
(verify) |
Quinethazone (INN, brand name Hydromox) is a thiazide-like diuretic used to treat hypertension. Common side effects include dizziness, dry mouth, nausea, and low potassium levels.
References
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.